Nektar TherapeuticsNKTRNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-1.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-17.78%
20248.42%
202337.53%
202227.58%
2021-33.41%
20209.70%
2019-150.42%
2018881.41%
201727.00%
2016-46.44%